Trokendi XR 50 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJB7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,460
Award facts
- Contract value 100% obligated
- $2,459.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) at a ceiling value of $2,459.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company leverages its comprehensive IDC with DLA to supply a diverse portfolio of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Trokendi XR, a neurological medication, represents one of many brand-name and generic drug products the company delivers through its federal contract vehicles. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's capability to fulfill federal pharmaceutical requirements through open competition and its established position as a prime vendor in the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FJB7W?
SPE2DR26FJB7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FJB7W worth?
The government has obligated $2,460 on SPE2DR26FJB7W.
Is contract SPE2DR26FJB7W an order under another contract?
Yes. SPE2DR26FJB7W is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB7W competed?
The extent of competition for SPE2DR26FJB7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award